E.H. Tan

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Nick Thatcher, Alex Y. Chang, Purvish M. Parikh et al. · The Lancet · 2005 · 2.1K citations

Medicine, Oncology, Palliative Oncology +9

Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Luis Paz‐Ares, E.H. Tan, Kenneth J. O’Byrne et al. · Annals of Oncology · 2017 · 522 citations · Full text

Medicine, Oncology, Pharmacology +16

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

Anne W.M. Lee, Stewart Y. Tung, Roger K.C. Ngan et al. · European Journal of Cancer · 2010 · 220 citations

Medicine, Oncology, Chemotherapy +12

Design of a prognostic index score for metastatic nasopharyngeal carcinoma

Yew Kwang Ong, Derrick Heng, Byung Ha Chung et al. · European Journal of Cancer · 2003 · 103 citations

Medicine, Cancer Biology, Oncology +12

PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial

Scott L. Weiss, Fran Balamuth, Elliot Long et al. · Trials · 2021 · 50 citations · Full text

Medicine, Child Health, Pediatrics +17